title: Optimization of a heterologous pathway for the production of flavonoids from glucose.
abstract: The development of efficient microbial processes for the production of flavonoids has been a metabolic engineering goal for the past several years, primarily due to the purported health-promoting effects of these compounds. Although significant strides have been made recently in improving strain titers and yields, current fermentation strategies suffer from two major drawbacks-(1) the requirement for expensive phenylpropanoic precursors supplemented into the media and (2) the need for two separate media formulations for biomass/protein generation and flavonoid production. In this study, we detail the construction of a series of strains capable of bypassing both of these problems. A four-step heterologous pathway consisting of the enzymes tyrosine ammonia lyase (TAL), 4-coumarate:CoA ligase (4CL), chalcone synthase (CHS), and chalcone isomerase (CHI) was assembled within two engineered l-tyrosine Escherichia coli overproducers in order to enable the production of the main flavonoid precursor naringenin directly from glucose. During the course of this investigation, we discovered that extensive optimization of both enzyme sources and relative gene expression levels was required to achieve high quantities of both p-coumaric acid and naringenin accumulation. Once this metabolic balance was achieved, however, such strains were found to be capable of producing 29 mg/l naringenin from glucose and up to 84 mg/l naringenin with the addition of the fatty acid enzyme inhibitor, cerulenin. These results were obtained through cultivation of E. coli in a single minimal medium formulation without additional precursor supplementation, thus paving the way for the development of a simple and economical process for the microbial production of flavonoids directly from glucose.
authors.affiliation: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. cnsantos@mit.edu
authors.forename: Christine Nicole S
authors.initials: CN
authors.lastname: Santos
authors.forename: Mattheos
authors.initials: M
authors.lastname: Koffas
authors.forename: Gregory
authors.initials: G
authors.lastname: Stephanopoulos
mesh_terms: D048168:Escherichia coli K12 / Q000201:enzymology / Q000235:genetics / Q000254:growth & development; D044950:Flavanones / Q000096:biosynthesis* / Q000235:genetics; D015870:Gene Expression; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D030781:Organisms, Genetically Modified / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D010940:Plant Proteins / Q000096:biosynthesis / Q000235:genetics; D029908:Pueraria / Q000201:enzymology / Q000235:genetics; D013549:Sweetening Agents / Q000378:metabolism / Q000494:pharmacology
chemical_list: D044950:Flavanones; D010940:Plant Proteins; D013549:Sweetening Agents; C005273:naringenin; D005947:Glucose